Lifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample

Abstract

CDKN2A mutation carriers in the general population have a much lower risk of melanoma than that suggested by estimates obtained from multiple-case families. The preponderance of familial clustering of melanoma occurs in families without identifiable mutations in CDKN2A.